140 results on '"Shioyama, Wataru"'
Search Results
2. External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2
3. Subclass phenotypes in patients with unprovoked venous thromboembolisms using a latent class analysis
4. Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2
5. Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2
6. External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2
7. Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib
8. Multicentre cohort study of the impact of percutaneous coronary intervention on patients with concurrent cancer and ischaemic heart disease
9. Clopidogrel Use in CYP2C19 Loss-of-Function Carriers With High Bleeding Risk After Percutaneous Coronary Intervention
10. Tenascin-C as a Potential Marker for Immunohistopathology of Doxorubicin-Induced Cardiomyopathy
11. FFR-CT is extremely useful in detecting hemodynamically significant left-main coronary artery stenosis with right coronary artery hypoplasia: A case report
12. Epidemiology of Acute Aortic Dissection in a General Population of 1.4 Million People in Japan ― Shiga Stroke and Heart Attack Registry ―
13. Acute myocardial infarction caused by tumor embolus originating from upper tract urothelial carcinoma: a case report
14. Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study
15. Lowering Uric Acid May Improve Prognosis in Patients With Hyperuricemia and Heart Failure With Preserved Ejection Fraction
16. Prognostic Impact of Cancer Activity on Clinically Relevant Bleeding Events After Percutaneous Coronary Intervention
17. Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated Myocarditis
18. A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related Myocarditis
19. Global thrombosis test for assessing thrombotic status and efficacy of antithrombotic diet and other conditions
20. Incidence and In-Hospital Mortality of Acute Myocardial Infarction: A Report from a Population-Based Registry in Japan
21. JS4-3 - Onco-Cardiology: Impact of cardiotoxicity control by onco-cardiologists on cancer treatment
22. Vascular Endothelial Growth Factor Receptor Inhibitors Impair Left Ventricular Diastolic Functions
23. Clinical significance of plasma endothelin-1 level after bosentan administration in pulmonary arterial hypertension
24. Serial Changes in Cardiac Strain and Contractility After Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies
25. Cardiovascular disease among pregnant women after anticancer therapy
26. Additional file 1 of Multicentre cohort study of the impact of percutaneous coronary intervention on patients with concurrent cancer and ischaemic heart disease
27. The efficacy of tocilizumab in a patient with pulmonary arterial hypertension associated with Castleman’s disease
28. Prognostic Effect of Incidental Pulmonary Embolism on Long-Term Mortality in Cancer Patients
29. Symptomatic Sinus Bradycardia in a Patient with Solitary Fibrous Tumor/Hemangiopericytoma Treated with Pazopanib
30. Multicentre Cohort Study of the Impact of Percutaneous Coronary Intervention on Patients With Concurrent Cancer and Ischaemic Heart Disease
31. Prognostic Impact of Cancer Activity on Clinically Relevant Bleeding Events After Percutaneous Coronary Intervention: A Retrospective Study
32. Coronary spastic angina in a multiple myeloma patient treated with bortezomib, lenalidomide, and dexamethasone
33. Fracture of a Retrievable Inferior Vena Cava Filter Placed for Cancer-associated Thrombosis in a Patient with Malignant Lymphoma
34. ASSESSMENT FOR DYNAMIC EFFECTS OF CISPLATIN-BASED CANCER CHEMOTHERAPY ON COAGULATION AND FIBRINOLYTIC SYSTEM
35. Bisoprolol transdermal patch treatment for patients with atrial fibrillation after noncardiac surgery: A single-center retrospective study of 61 patients
36. Irreversible severe cardiotoxicities except for QTc interval prolongation associated with Osimertinib
37. Single-drug approach with rivaroxaban: A case of successful anticoagulation against cancer-associated thrombosis
38. Oral Anticoagulants in Japanese Patients with Atrial Fibrillation and Active Cancer
39. Aortic Dissection and Cardiac Dysfunction Emerged Coincidentally During the Long-Term Treatment with Angiogenesis Inhibitors for Metastatic Renal Cell Carcinoma
40. Onco-Cardiology: Impact of cardiotoxicity control by onco-cardiologists on cancer treatment
41. Molecular Characterization of Striated Muscle-Specific Gab1 Isoform as a Critical Signal Transducer for Neuregulin-1/ErbB Signaling in Cardiomyocytes
42. Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2
43. MO2-16-2 - Irreversible severe cardiotoxicities except for QTc interval prolongation associated with Osimertinib
44. Cardiotoxicity Associated with Trastuzumab in Breast Cancer Patients: Definition of Cancer Therapeutics-Related Cardiac Dysfunction (CTRCD)
45. Endothelial Gab1 Deletion Accelerates Angiotensin II-Dependent Vascular Inflammation and Atherosclerosis in Apolipoprotein E Knockout Mice
46. Docking Protein Gab1 Is an Essential Component of Postnatal Angiogenesis After Ischemia via HGF/c-Met Signaling
47. Pulmonary Arterial Hypertension Associated with Chronic Active Epstein-Barr Virus Infection
48. Pulmonary hypertension associated with bone marrow transplantation
49. SHP2 mediates gp130-dependent cardiomyocyte hypertrophy via negative regulation of skeletal alpha-actin gene
50. Abstract 5803: Interaction of Docking Protein Gab1 With Tyrosine Phosphatase SHP2 Regulates Hepatocyte Growth Factor-dependent ERK5 Activation and Upregulation of KLF2 in the Vascular Endothelium
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.